T1	Participants 111 137	central precocious puberty
T2	Participants 228 260	central precocious puberty (CPP)
T3	Participants 503 518	CPP in children
T4	Participants 609 664	Twenty-two U.S. medical centers (including Puerto Rico)
T5	Participants 688 791	Children diagnosed with CPP (n = 84), who were either treatment naive or previously treated with GnRHa,
